Catalog Advanced Search

Search by Categories
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 2020 ACCP Virtual Journal Club November | Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir - LIVE

    Contains 5 Component(s), Includes Credits Includes a Live Web Event on 11/18/2020 at 4:15 PM (EST)

    Presented by: Gilbert J. Burckart, PharmD; Jeremiah D. Momper, PharmD, PhD and Andre Dallmann, PhD

    Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir- LIVE

    ACCP Virtual Journal Club Webinars

    Live Session: Wednesday, November 18, 2020 from 2:00-3:00 PM ET

    On Demand: November 18, 2020 to November 18, 2023

    See Handouts tab for Continuing Education information on IPCE credits.


    Gilbert J. Burckart, PharmD

    Associate Director for Pediatrics

    Dr. Gilbert Burckart is presently Associate Director for Pediatrics, Office of Clinical Pharmacology at the US Food & Drug Administration (FDA).  Prior to coming to the FDA, Dr. Burckart served on the faculties of four Univs (Buffalo, Tennessee, Pittsburgh and Southern California) as a Professor of Pharmacy, Pediatrics and Surgery for 33 yrs. In the past, Dr. Burckart has served as President of the American Coll of Clinical Pharmacy and President of the American Coll of Clinical Pharmacology®. He moved to the FDA in 2008 where his duties include regulatory science and educational programs in Pediatric Clinical Pharmacology within the Office of Clinical Pharmacology and participation in the FDA’s Pediatric Review Committee.

    Jeremiah D. Momper, PharmD, PhD

    Associate Professor

    Jeremiah Momper, PharmD, PhD is an Associate Professor at the Univ of California, San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences. Dr. Momper’s research focuses on the application of quantitative pharmacology approaches to optimize the development and clinical use of drugs. Current research directions include evaluation of potential therapies for HIV infection in infants and pregnant women and the use of model-based methods to support scientific decision making in drug development. Dr. Momper directs the Drug Metabolism & Pharmacokinetics research laboratory at UC San Diego concentrated on novel quantitative bioanalytical methods, in vitro ADME assays, and preclinical and clinical pharmacokinetic studies.

    André Dallmann, PhD

    Scientist Systems Pharmacology

    Dr. André Dallmann works as Scientist for Systems Pharmacology at Bayer, Germany. He completed his PhD in Clinical Pharmacy at the Univ of Münster, Germany, in 2017. Thereafter, he worked as a postdoctoral researcher at the Pediatric Pharmacology & Pharmacometrics Research Ctr at the Univ Children’s Hospital Basel in Switzerland and joined the department of Clinical Pharmacometrics at Bayer in 2018. His research interests focus on in vitro to in vivo extrapolation for oral drug formulations, mechanistic modeling of drug-drug interactions and the exploration of obstetric and neonatal pharmacology through PBPK modeling.

    Otito Frances Iwuchukwu, RPh, PhD (Moderator)

    Assistant Professor

    Dr. Iwuchukwu is a Pharmacist Scientist who obtained her PhD in Pharmaceutical Sciences with specialization in Drug Metabolism and Pharmacokinetics/Medicinal Chemistry from Temple University School of Pharmacy in Philadelphia, Pennsylvania. She then went on to complete an NIH T-32 cardiovascular pharmacogenomics focused training fellowship in Clinical Pharmacology at Vanderbilt University under the mentorship of the program Director, Dr. Michael Stein. During her training, she served as the Chief fellow for the 2014/2015 academic year and was a recipient of the 2015 Clinical Pharmacology Fellows Teaching Award. She completed and received her certification in the NIH sponsored Principles of Clinical Pharmacology course for the 2015 academic cycle. After her training, she transitioned to academic pharmacy and is currently an Assistant Professor in the Division of Pharmaceutical Sciences at Fairleigh Dickinson University’s School of Pharmacy in Florham Park, New Jersey where she teaches and conducts pharmacogenomics research. She is also an active member of the Clinical Pharmacogenomics Implementation consortium, where she contributes to the consortium’s mission of providing guidelines that enable the translation of genetic laboratory test results into actionable prescribing decisions for drugs with validated pharmacogenetic associations.

  • 2020 ACCP Webinar November | Best Practices in Treating Opioid Use Disorder in Pregnancy -LIVE

    Contains 4 Component(s), Includes Credits Includes a Live Web Event on 11/04/2020 at 2:00 PM (EST)

    Treatment of Opioid Use Disorder during pregnancy presents unique challenges. During this webinar you will learn treatment strategies for Opioid Use Disorder during pregnancy that provide the best outcomes based on current evidence.

    ACCP 2020 Webinar - Best Practices in Treating Opioid Use Disorder in Pregnancy

    Live webinar: November 4, 2020 from 2:00 - 3:00 PM ET 

    On-demand webinar recording:  November 4, 2020 to November 4, 2023

    Why is this article important to your practice? 

    Treatment of Opioid Use Disorder during pregnancy presents unique challenges. During this webinar you will learn treatment strategies for Opioid Use Disorder during pregnancy that provide the best outcomes based on current evidence. 

    Target Audience: 

    Inter-professional team of Physicians, Pharmacists, PhDs, Physician Assistants and Nurses.

    Learning Objectives: 

    After completing this activity, the learner will be able to:

    1. Discuss the evidence supporting pharmacotherapy in the pregnant patient with Opioid Use Disorder (OUD);

    2. Describe patient-centered treatment strategies for OUD during pregnancy;

    3. Explain the impact of pharmacotherapy for OUD during pregnancy on the fetus and newborn;

    4. Recognize ways to reduce stigma and improve recovery in pregnant women with OUD.

    To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.



    Elizabeth E. Krans, MD

    Assistant Professor, Dept of Obstetrics, Gynecology & Reproductive Sciences

    Coming soon

    Jennifer Wohl, DHSc, PA-C

    Physician Assistant

    Coming soon

  • 2020 ACCP Journal of Clinical Pharmacology Journal CE | Monthly CE Offerings

    Contains 40 Component(s), Includes Credits

    The American College of Clinical Pharmacology® monthly journal article continuing education offerings from The Journal of Clinical Pharmacology.

    Registration and Pricing

    The American College of Clinical Pharmacology® (ACCP) offers a monthly article from the The Journal of Clinical Pharmacology (JCP) for continuing education credit. See the CE Info tab for more information on credits. The ACCP JCP Journal CE articles are priced and packaged for January through December of the same calendar year. Packages are available at no cost to ACCP Members and $75/calendar year to Non-members. Once registered, learners have access to all of the Journal CE articles for the calendar year as the articles are released.

    To register, log into your ACCP online profile and then register by clicking the green Register button at the top right. Follow the online prompts to complete the registration process and to receive your registration confirmation. If you do not have an ACCP profile, one must be created before you can register for the Journal CE articles. If you do not know if you have a profile, please contact KLevy@ACCP1.org for further information to avoid creating duplicate profiles. Please address all other questions to CE@ACCP1.org.

    Requirements for Credits

    All requirements for claiming CE credits are listed in the CE Info tab. Continuing education credits and certificates must be claimed within 30-days of completing the monthly article offering. Continuing Pharmacy Education (CPE) data is uploaded into the CPE Monitor at the end of each month. The pharmacist's NABP# and MMDD of birth must be updated into their ACCP Profile or emailed to CE@ACCP1.org in order to have CPE credits automatically uploaded to the CPE Monitor.

    CE Expiration 12/31/2023




     

  • PMWS 5: Innovative Drug Development in Asia: Challenges & Opportunities | 2020 Virtual ACCP Annual Meeting - On Demand

    Contains 5 Component(s), Includes Credits

    Presented by: Haiyan Li, MD, Peking Univ Third Hosp, China, Gailing Li, PhD, Janssen Research & Development LLC, Nilima A. Kshirsagar, MBBS, MD, National Chair, Clinical Pharmacology, ICMR Gov’t of India, Junko Sato, PhD, Director, Int’l Cooperation, Pharmaceuticals & Medical Devices Agency, Yan Ren, PhD, Director, Clinical Pharmacology, BeiGene Ltd and Howard Lee, MD, PhD, Clinical Pharmacology & Therapeutics, Seoul National Univ Hosp & Coll of Medicine

    Pre-meeting Workshop 5: Individualized Drug Therapy: Innovative Drug Development in Asia: Challenges & Opportunities - On Demand

    2020 Virtual ACCP Annual Meeting

    See Handouts tab for Continuing Education information on IPCE credits.


  • PMWS 2: Individualized Drug Therapy: Maximally-precise Drug Therapy for Each Individual Patient, at the Bedside, in a Community Hospital Setting | 2020 Virtual ACCP Annual Meeting - On Demand

    Contains 5 Component(s), Includes Credits

    Presented by: Michael N. Neely, MD, Chief, Infectious Diseases, Director, Laboratory of Applied Pharmacokinetics & Bioinformatics, Children’s Hosp Los Angeles, Professor of Pediatrics & Clinical Scholar, Keck School of Medicine, Univ of Southern California and George Drusano, MD, Professor of Medicine, Director, Inst for Therapeutic Innovation, Coll of Medicine, Univ of Florida

    Pre-meeting Workshop 2: Individualized Drug Therapy: Maximally-precise Drug Therapy for Each Individual Patient, at the Bedside, in a Community Hospital Setting - On Demand

    2020 Virtual ACCP Annual Meeting

    See Handouts tab for Continuing Education information on IPCE credits.


  • PMWS 1: Analysis & Reporting of QTc Prolongation Potential of New Drugs Using R Tools, Expectations & General Guidance for Regulatory Submissions | 2020 Virtual ACCP Annual Meeting - On Demand

    Contains 5 Component(s), Includes Credits

    Presented by: Steve Riley, PharmD, PhD, Senior Director, Clinical Pharmacology, Pfizer Inc, Ana Ruiz-Garcia, PharmD, PhD, Senior Principal Scientist I, Metrum Research Group LLC and Dhananjay D. Marathe, PhD, Principal Scientist, Quantitative Pharmacology & Pharmacometrics, Merck & Co Inc

    Pre-meeting Workshop 1: Analysis & Reporting of QTc Prolongation Potential of New Drugs Using R Tools, Expectations & General Guidance for Regulatory Submissions - On Demand

    2020 Virtual ACCP Annual Meeting

    See Handouts tab for Continuing Education information on IPCE credits.


  • 2020 ACCP Annual Meeting | Post-event Self-assessment-SYMPOSIA

    Contains 40 Component(s), Includes Credits

    Thank you for attending the 2020 ACCP Annual Meeting. Please complete the Survey Monkey course evaluation for each session you attended and then return to this page to complete a self-assessment of your post-course knowledge. After completing the self-assessment, be sure to claim and print your certificate for the course. As with any educational event, please only complete self-assessments and claim certificates for the sessions which you attended. Credits must be claimed by October 31, 2020.

    The 2020 Annual Meeting Self-assessment & CE Certificates program is available only to registered attendees. Please follow the individual course links in the ACCP mobile app to complete your session evaluations (in Survey Monkey) and then return to this page to complete a self-assessment of your post-course knowledge. There is no minimum score to pass. After completing the self-assessment, be sure to claim and print your certificate for the session.  As with any educational event, please only complete self-assessments and claim certificates for the sessions you attended.

    Members Obtain Free CE Credits from JCP Articles and Webinars!

    AM2018 Pre-meeting Self-assessment & Faculty Feedback

    August 2018 – ACCP 2018 Annual Meeting

    Why is this pre-meeting self-assessment important to you? 

    Educational research demonstrates that pre-course self-assessments are a valuable educational tool for learners to identify areas of strength and weakness in their pre-course knowledge. In a multitrack educational meeting, a pre-meeting self-assessment helps guide the learner to select tracks or courses based upon self-identified areas of weakness. Finally, when provided to the course faculty beforehand, the pre-course assessment results provide greater clarity as to the learners’ needs and allows for pre-course adjustment of content.

    ACPE Accreditation Statement

    The American College of Clinical Pharmacology is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

    UAN: 0238-0000-18-039-H01-P – ACPE 1 Contact Hours

    Activity Type:  Knowledge-based   Format:  Home-study   Target Audience: ‘P’

    ACCME Accreditation Statement

    The American College of Clinical Pharmacology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

    ACCME Designation Statement

    The Accreditation Council for Continuing Medical Education designates this enduring material CE activity for 1 AMA PRA Category 1TM credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Target Audience

    Interprofessional team of Physicians, Pharmacists, PhDs, Nurse Practitioners and Physician Assistants who are registered to attend the ACCP 2018 Annual Meeting.

    Learning Objectives

    After completing this activity, the learner will be able to:

    • Identify personal areas of strength and weakness in knowledge of the educational content of the Annual Meeting program;
    • Review and further investigate the rationale of the pre-assessment questions and correct answers as an educational tool;
    • Utilize the individual pre-assessment results to inform a plan for selecting courses during the Annual Meeting;
    • Provide pre-meeting Faculty feedback to inform presentation preparations targeted at the learner's educational needs.

    Requirements to Receive Credit

    In order to receive CE credit, the learner must be registered for the ACCP 2018 Annual Meeting, must register for the educational activity on the ACCP website, complete the online learning self-assessment (pre-test), complete the online course evaluation and print the certificate.

    Online Location: How to Print CE Certificate

    https://accp1.org/documents/CommPartners/ReprintCECertificates.pdf

    Disclosures: 

    Planner: Linna Walz, RN, BSN, MBA/MHA, MSEd, Director of Education, American College of Clinical Pharmacology, developed the continuing education portion of this activity (target audience, gap analysis, objectives) and has nothing to disclose.

    Planner: Dionna Green, MD, Deputy Director, Office of Pediatric Therapeutics, Office of the Commissioner, US Food & Drug Administration and ACCP Annual Meeting Program Committee Co-chair, has nothing to disclose.

    Schedule & Fees

    The ACCP 2018 Annual Meeting Pre-meeting Self-assessment is provided free of charge to 2018 Annual Meeting registrants. The Pre-meeting Self-assessment must be completed on or before September 21, 2018.

    Acknowledgement of Financial Support

    No financial support was received for this educational activity.

    Home Study Initial Release and Expiration Dates

    Date of Issuance:  8/3/2018

    Expiration Date:   9/21/2018

    Online Location for Course: http://www.accp1.org/ACCP1/Eve...

  • 2020 ACCP Annual Virtual Meeting | Post-event Self-assessment-WORKSHOPS

    Contains 6 Component(s), Includes Credits

    Thank you for attending the 2020 ACCP Annual Virtual Meeting Pre-meeting Workshop(s). Please complete the Survey Monkey course evaluation for each workshop you attended and then return to this page to complete a self-assessment of your post-course knowledge. After completing the self-assessment, be sure to claim and print your certificate for the course. As with any educational event, please only complete self-assessments and claim certificates for the workshops which you attended. Credits must be claimed by October 31, 2020.

    The 2020 Annual Virtual Meeting Post-meeting Workshops Self-assessment & CE Certificates program is available only to registered attendees. Please follow the individual course links in the ACCP mobile app to complete your workshop evaluations (in Survey Monkey) and then return to this page to complete a self-assessment of your post-course knowledge. There is no minimum score to pass. After completing the self-assessment, be sure to claim and print your certificate for the workshop!  As with any educational event, please only complete self-assessments and claim certificates for the workshop(s) which you attended.

    Members Obtain Free CE Credits from JCP Articles and Webinars!

    AM2018 Pre-meeting Self-assessment & Faculty Feedback

    August 2018 – ACCP 2018 Annual Meeting

    Why is this pre-meeting self-assessment important to you? 

    Educational research demonstrates that pre-course self-assessments are a valuable educational tool for learners to identify areas of strength and weakness in their pre-course knowledge. In a multitrack educational meeting, a pre-meeting self-assessment helps guide the learner to select tracks or courses based upon self-identified areas of weakness. Finally, when provided to the course faculty beforehand, the pre-course assessment results provide greater clarity as to the learners’ needs and allows for pre-course adjustment of content.

    ACPE Accreditation Statement

    The American College of Clinical Pharmacology is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

    UAN: 0238-0000-18-039-H01-P – ACPE 1 Contact Hours

    Activity Type:  Knowledge-based   Format:  Home-study   Target Audience: ‘P’

    ACCME Accreditation Statement

    The American College of Clinical Pharmacology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

    ACCME Designation Statement

    The Accreditation Council for Continuing Medical Education designates this enduring material CE activity for 1 AMA PRA Category 1TM credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Target Audience

    Interprofessional team of Physicians, Pharmacists, PhDs, Nurse Practitioners and Physician Assistants who are registered to attend the ACCP 2018 Annual Meeting.

    Learning Objectives

    After completing this activity, the learner will be able to:

    • Identify personal areas of strength and weakness in knowledge of the educational content of the Annual Meeting program;
    • Review and further investigate the rationale of the pre-assessment questions and correct answers as an educational tool;
    • Utilize the individual pre-assessment results to inform a plan for selecting courses during the Annual Meeting;
    • Provide pre-meeting Faculty feedback to inform presentation preparations targeted at the learner's educational needs.

    Requirements to Receive Credit

    In order to receive CE credit, the learner must be registered for the ACCP 2018 Annual Meeting, must register for the educational activity on the ACCP website, complete the online learning self-assessment (pre-test), complete the online course evaluation and print the certificate.

    Online Location: How to Print CE Certificate

    https://accp1.org/documents/CommPartners/ReprintCECertificates.pdf

    Disclosures: 

    Planner: Linna Walz, RN, BSN, MBA/MHA, MSEd, Director of Education, American College of Clinical Pharmacology, developed the continuing education portion of this activity (target audience, gap analysis, objectives) and has nothing to disclose.

    Planner: Dionna Green, MD, Deputy Director, Office of Pediatric Therapeutics, Office of the Commissioner, US Food & Drug Administration and ACCP Annual Meeting Program Committee Co-chair, has nothing to disclose.

    Schedule & Fees

    The ACCP 2018 Annual Meeting Pre-meeting Self-assessment is provided free of charge to 2018 Annual Meeting registrants. The Pre-meeting Self-assessment must be completed on or before September 21, 2018.

    Acknowledgement of Financial Support

    No financial support was received for this educational activity.

    Home Study Initial Release and Expiration Dates

    Date of Issuance:  8/3/2018

    Expiration Date:   9/21/2018

    Online Location for Course: http://www.accp1.org/ACCP1/Eve...

  • 2020 ACCP Webinar October | Lessons Learned: Perspectives from Government, Academia and Industry-ON DEMAND

    Contains 4 Component(s), Includes Credits

    This webinar series aims to provide career development tools to Students, Trainees & Early-stage Professionals entering or at the beginning of their careers in the field clinical pharmacology.

    ACCP 2020 Webinar - Lessons Learned from Government, Academia and Industry-On-Demand

    On-demand webinar recording:  October 7, 2020 to October 7, 2023

    Why is this article important to your practice? 

    This webinar series aims to provide career development tools to Students, Trainees & Early-stage Professionals entering or at the beginning of their careers in the field clinical pharmacology. 

    Target Audience: 

    Physicians, Pharmacists, and other professionals requiring training in the professional competencies of peer reviewing. 

    Learning Objectives: 

    After completing this activity, the learner will be able to:

    1. Identify behaviors associated with facilitating successful career advancement;
    2. Learn from specific examples of professional conduct that can be applied to their own career circumstances enabling them to better navigate or overcome barriers to career advancement;
    3. Demonstrate domain specific (i.e., academics, industry, and/or regulatory) knowledge regarding career advancement in the field of clinical pharmacology;
    4. Gain practical insights into avoiding and addressing potential career missteps.

    To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.

    Manjunath (Amit) P. Pai, PharmD

    Associate Professor, Coll of Pharmacy, Univ of Michigan

    John D. Davis PhD, FCP, MRPharmS

    Executive Director & Head, Clinical Pharmacology, Regeneron Pharmaceuticals Inc

    Dionna Green, MD, FCP

    Deputy Director, Office of Pediatric Therapeutics, US Food & Drug Administration

  • 2020 ACCP Virtual Journal Club June | Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval-An Analysis of ECGs From the IQ-CSRC Study-On Demand

    Contains 5 Component(s), Includes Credits

    Presented by: Borje Darpo, MD, PhD

    Evaluation of the Effect of QT-Positive Drugs on the JTpeak Interval-An Analysis of ECGs From the IQ-CSRC Study- On Demand

    ACCP Virtual Journal Club Webinars

    Live Session: Wednesday, June 17, 2020 from 2:00-3:00 PM ET

    On Demand: June 17, 2020 to June 17, 2023

    See Handouts tab for Continuing Education information on IPCE credits.


    Gilbert J. Burckart, PharmD

    Associate Director for Pediatrics

    Dr. Gilbert Burckart is presently Associate Director for Pediatrics, Office of Clinical Pharmacology at the US Food & Drug Administration (FDA).  Prior to coming to the FDA, Dr. Burckart served on the faculties of four Univs (Buffalo, Tennessee, Pittsburgh and Southern California) as a Professor of Pharmacy, Pediatrics and Surgery for 33 yrs. In the past, Dr. Burckart has served as President of the American Coll of Clinical Pharmacy and President of the American Coll of Clinical Pharmacology®. He moved to the FDA in 2008 where his duties include regulatory science and educational programs in Pediatric Clinical Pharmacology within the Office of Clinical Pharmacology and participation in the FDA’s Pediatric Review Committee.